Purpose To evaluate the long-term outcomes of radiofrequency ablation (RFA) as a first-line
therapy for early-stage hepatocellular carcinoma (HCC) and determine the prognostic …

PURPOSE: To investigate the efficacy of radiofrequency ablation (RFA) for hepatocellular
carcinoma (HCC), and the prognostic factors for post-RFA survival rate. METHODS: From …

The purpose of this study was to evaluate the long-term survival results and complications of
percutaneous radiofrequency ablation (RFA) in patients with early-stage hepatocellular …

Background Radiofrequency ablation (RFA) offers an alternative treatment in some
unresectable hepatocellular carcinoma (HCC) patients with disease confined to the liver. We …

For the treatment of small hepatocellular carcinoma (HCC), radiofrequency ablation (RFA) is
in some centers considered a first‐line therapeutic option. However, such a strategy is still …

Percutaneous radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) was
introduced in Japan in 1999. It has been established as a main local treatment method …

Background Despite the high complete necrosis rate of radiofrequency ablation (RFA),
tumor recurrence, either local tumor recurrence or new tumor formation, remains a …

PURPOSE: To perform a prospective, intention-to-treat clinical trial to determine the long-
term survival rates of patients with hepatic cirrhosis and early-stage hepatocellular …

Abstract Background and Aims Percutaneous radiofrequency ablation (RFA) demonstrated
good results for the treatment of hepatocellular carcinoma (HCC) in cirrhotic patients; it is still …

BACKGROUND & AIMS: The aim was to assess 10-year outcomes of radiofrequency
ablation as a first-line therapy of early-stage hepatocellular carcinoma with an analysis of …